About Sanofi
Sanofi is a company based in Paris (France) founded in 1973 by Jean Rene Sautier was acquired by Beximco Pharma in September 2021. It operates as a AI-as-a-Service, Professional Services, and HealthTech. Sanofi has completed 32 acquisitions, including Ablynx, Amunix and BMP Sunstone. Sanofi offers products and services including Vaccines, Medicines, and Consumer Healthcare (Opella). Sanofi operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter Paris, France
- Founders Jean Rene Sautier
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biotron Limited
-
Annual Revenue
$0 (USD)0as on Jun 30, 2025
-
Net Profit
$-210.5 K (USD)90.73as on Jun 30, 2025
-
EBITDA
$-1.35 M (USD)59.91as on Jun 30, 2025
-
Latest Funding Round
-
Investors
Blackstone
& 8 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Ablynx
& 31 more
-
Acquired by
Beximco Pharma
(Sep 14, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sanofi
Sanofi is a publicly listed company on the ASX with ticker symbol BIT in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Sanofi
Sanofi offers a comprehensive portfolio of products and services, including Vaccines, Medicines, and Consumer Healthcare (Opella). The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Vaccines are developed for infectious disease prevention.
Medicines are provided for various therapeutic areas.
Consumer healthcare products are offered for daily wellness.
Unlock access to complete
Unlock access to complete
Software Development Team
176 people
Leadership Team
103 people
Head Team
41 people
Global Team
31 people
Finance and Accounting
30 people
Product Management Team
28 people
Operations Team
27 people
Sales and Marketing
24 people
Unlock access to complete
Funding Insights of Sanofi
- Total Funding Total Funding
- Total Rounds 16
- Last Round Last Round
-
First Round
First Round
(06 May 2009)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Post-IPO - Sanofi | Valuation |
investors |
|
| Jun, 2022 | Amount | Grant - Sanofi | Valuation |
investors |
|
| Mar, 2022 | Amount | Post-IPO - Sanofi | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sanofi
Sanofi has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Blackstone, Gates Foundation and Beximco Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investment management is provided across multiple asset classes.
|
Founded Year | Domain | Location | |
|
Provides banking accounts, loans, credit cards, and digital services for individuals and businesses.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sanofi
Sanofi has strategically engaged in corporate development activities, having acquired 32 companies. Notable acquisitions include Ablynx, Amunix and BMP Sunstone. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Microglia-focused therapeutics for neurodegenerative diseases are developed.
|
2020 | ||||
|
Prescription drugs are distributed across China by the corporation.
|
2019 | ||||
|
mRNA immunotherapies for cancer are developed using nanoparticle delivery systems.
|
2019 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Sanofi
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sanofi Comparisons
Competitors of Sanofi
Sanofi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sanofi
Frequently Asked Questions about Sanofi
When was Sanofi founded?
Sanofi was founded in 1973 and raised its 1st funding round 36 years after it was founded.
Where is Sanofi located?
Sanofi is headquartered in Paris, France.
Who is the current CEO of Sanofi?
Paul Hudson is the current CEO of Sanofi.
What does Sanofi do?
Sanofi is established as a biopharmaceutical company focused on research and development, leveraging artificial intelligence to innovate healthcare solutions. The company is engaged in multiple therapeutic areas including immunology, neurology, oncology, rare blood disorders, rare diseases, and vaccines. Operations are supported by advanced technology platforms and clinical trials to develop new treatments. Sanofi is committed to sustainable healthcare access and environmental impact reduction. Partnerships and external innovation are pursued globally across North America, Europe, and China to enhance its offerings. The companys pipeline includes 82 compounds in clinical development and 24 trials in phase 3, targeting improved health outcomes.
Who are the top competitors of Sanofi?
Sanofi's top competitors include Merck, Roivant Sciences and AbbVie.
What products or services does Sanofi offer?
Sanofi offers Vaccines, Medicines, and Consumer Healthcare (Opella).
Is Sanofi publicly traded?
Yes, Sanofi is publicly traded on ASX under the ticker symbol BIT.
How many acquisitions has Sanofi made?
Sanofi has made 32 acquisitions, including Ablynx, Amunix, and BMP Sunstone.
Who are Sanofi's investors?
Sanofi has 9 investors. Key investors include Blackstone, Gates Foundation, Beximco Pharma, European Union, and USAGov.
What is Sanofi's ticker symbol?
The ticker symbol of Sanofi is BIT on ASX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.